| 04/30/2026 3:32 PM | CytoDyn (1175680) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/22/2026 4:21 PM | CytoDyn (1175680) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 04/08/2026 4:15 PM | CytoDyn (1175680) Filer | Form 424B3 | |
| 04/08/2026 7:30 AM | CytoDyn (1175680) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 03/25/2026 4:16 PM | CytoDyn (1175680) Filer | Form 424B3 | |
| 03/24/2026 4:20 PM | Blok Tyler (1990234) Reporting CytoDyn (1175680) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:20 PM | Brunke Karen J (1922660) Reporting CytoDyn (1175680) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:21 PM | CytoDyn (1175680) Issuer Dunlap Ryan (1554742) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:22 PM | CytoDyn (1175680) Issuer Hoffman Robert E. (1166288) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:22 PM | CytoDyn (1175680) Issuer Lalezari Jacob P (2001963) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:23 PM | CytoDyn (1175680) Issuer Ndhlovu Lishomwa C (1898357) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CYDY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/24/2026 4:23 PM | CytoDyn (1175680) Issuer SIMES STEPHEN M (905479) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:24 PM | CytoDyn (1175680) Issuer Urbach Tanya Durkee (1897672) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:15 PM | CytoDyn (1175680) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 4:15 PM | CytoDyn (1175680) Filer | Form 424B3 | |
| 03/05/2026 7:35 AM | CytoDyn (1175680) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 4:15 PM | CytoDyn (1175680) Filer | Form 424B3 | |
| 01/09/2026 7:30 AM | CytoDyn (1175680) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 12/22/2025 4:15 PM | CytoDyn (1175680) Filer | Form 424B3 | |
| 12/16/2025 11:15 PM | CytoDyn (1175680) Filer | Form EFFECT | |
| 12/10/2025 4:16 PM | CytoDyn (1175680) Filer | Form POS AM | |
| 12/02/2025 11:15 PM | CytoDyn (1175680) Filer | Form EFFECT | |
| 12/02/2025 4:15 PM | CytoDyn (1175680) Filer | Form 424B3 | |
| 12/01/2025 7:40 AM | CytoDyn (1175680) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/21/2025 4:15 PM | CytoDyn (1175680) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/04/2025 4:15 PM | CytoDyn (1175680) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 11/03/2025 4:15 PM | CytoDyn (1175680) Filer | Form DEFA14A | |
| 11/03/2025 7:38 AM | CytoDyn (1175680) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/10/2025 7:30 AM | CytoDyn (1175680) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/30/2025 4:15 PM | CytoDyn (1175680) Filer | Form DEFA14A | |
| 09/29/2025 3:45 PM | CytoDyn (1175680) Filer | Form 424B3 | |
| 09/29/2025 3:30 PM | CytoDyn (1175680) Filer | Form DEF 14A | |
| 09/19/2025 3:30 PM | CytoDyn (1175680) Filer | Form PRE 14A | |
| 08/21/2025 11:15 PM | CytoDyn (1175680) Filer | Form EFFECT | |
| 07/25/2025 4:04 PM | CytoDyn (1175680) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 07/25/2025 3:34 PM | CytoDyn (1175680) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 05/22/2025 7:30 PM | CytoDyn (1175680) Issuer Hoffman Robert E. (1166288) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/22/2025 7:31 PM | CytoDyn (1175680) Issuer Hoffman Robert E. (1166288) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/16/2025 4:15 PM | CytoDyn (1175680) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/16/2025 4:17 PM | CytoDyn (1175680) Filer | Form 424B3 | |